- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Brenton Fargnoli Discusses the Creation of a Learning Health System
Brenton Fargnoli, MD, medical director of value-based care and director of product marketing and strategy at Flatiron Health, predicts the future of the learning health system in the United States.
Brenton Fargnoli, MD, medical director of value-based care and director of product marketing and strategy at Flatiron Health, predicts the future of the learning health system in the United States.
Transcript
Do you see the trappings of a real, learning health system taking place in the United States? How much further do we have to go before it is fully functioning?
In 2007, the Institute of Medicine came out and called for the establishment of the learning healthcare system. The notion that we can improve patient outcomes from learning from every single patient.
Now we’re 10 years later and I think that what we’ve learned is that before we can have this learning healthcare system we really need a learning healthcare platform and that’s really a challenging data problem. Particularly so in oncology. You need to take in and bring together structured [electronic health record] data, curated data from unstructured notes and even additional data sources altogether into this consistent overarching data representation. Then do that on a national scale. Connecting community oncologists across the country on a common platform and so this all takes time.
We’re in the early innings, but we’re getting there.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
EMBARK Data Show Continued Improvements With DMD Gene Therapy
March 19th 2025Data from the EMBARK trial of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) show that benefits in functional outcomes, gene expression, and muscle imaging persist 2 years after receiving the gene therapy.
Read More
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More
